| Stage | KR | % of rev | IMKTA | % of rev | Gap · A − B |
|---|---|---|---|---|---|
| Revenue | $34.6B | 100.00% | $1.4B | 100.00% | KR ×25.30 |
| Gross profit | $7.9B | 22.70% | $332M | 24.30% | IMKTA +1.6pp |
| Operating income | $971M | 2.80% | $34M | 2.52% | KR +0.3pp |
| Pre-tax income | $840M | 2.43% | $33M | 2.41% | 0.0pp |
| Net income | $642M | 1.85% | $26M | 1.89% | 0.0pp |
| Stage | KR | IMKTA | Gap · A − B |
|---|---|---|---|
| Revenue | $34.6B100.00% | $1.4B100.00% | KR ×25.30 |
| Gross profit | 22.70%$7.9B | 24.30%$332M | IMKTA +1.6pp |
| Operating income | 2.80%$971M | 2.52%$34M | KR +0.3pp |
| Pre-tax income | 2.43%$840M | 2.41%$33M | 0.0pp |
| Net income |
| 1.85%$642M |
| 1.89%$26M |
| 0.0pp |
No disclosed counterparties: IMKTA.
None